AAVnerGene Inc. Partners with Klotho Neurosciences, Inc. to Make Klotho’s Gene Therapy AssetsRead MoreAAVnerGene Inc. Partners with Klotho Neurosciences, Inc. to Make Klotho’s Gene Therapy Assets
AAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Vector Technology Platform for Gene TherapyRead MoreAAVnerGene and TFBS Bioscience Announce Collaboration to Develop Innovative AAV Vector Technology Platform for Gene Therapy
AAVone System Generates over 5E15 VG/L AAV9 Vectors in Suspension HEK 293 Cells. ASGCT 2025, Poster 1974Read MoreAAVone System Generates over 5E15 VG/L AAV9 Vectors in Suspension HEK 293 Cells. ASGCT 2025, Poster 1974
AAV(Eye): A Promising Template for AAV Capsid Engineering in NHP RetinasRead MoreAAV(Eye): A Promising Template for AAV Capsid Engineering in NHP Retinas
AAVone System Achieved High AAV Productivity in Large Scale Testing (XDR200)Read MoreAAVone System Achieved High AAV Productivity in Large Scale Testing (XDR200)
🧬Driving AAV Vector Design Innovation and Therapeutic Applications: Our team spoke at SAPA-CT’s 11th Annual meetingRead More🧬Driving AAV Vector Design Innovation and Therapeutic Applications: Our team spoke at SAPA-CT’s 11th Annual meeting